Debt-to-Equity Ratio
Higher than 12% of Healthcare sector peers
Updated 167h ago
Sector Performance
12th percentileRXRX
0.02x
Sector Median
0.43x
Sector Avg
0.81x
Deep Analysis
The debt-to-equity ratio measures how much of a company’s financing comes from debt compared to shareholders’ equity.
At 0.02x, Recursion Pharmaceuticals has almost no debt relative to equity, placing it well below the healthcare sector median of 0.43x and in the 12th percentile among peers. There is no trend to assess because year-over-year and quarter-over-quarter changes are both listed as not available (N/A). The combination of an extremely low debt level with no trend data suggests minimal financial leverage risk, but also offers no indication of whether leverage is increasing or decreasing. This metric supports the overall CAUTIOUS verdict because the ultra-low ratio may signal that the company is underutilizing debt to fund growth, which can limit capital for research and development in a capital-intensive biotech industry.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about RXRX?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
How does RXRX's Debt-to-Equity Ratio compare to its sector?
RXRX's Debt-to-Equity Ratio of 0.02x compares to a Healthcare sector median of 0.43x, placing it in the 12th percentile.
Who are RXRX's closest peers by Debt-to-Equity Ratio?
The closest Healthcare peers by Debt-to-Equity Ratio include: BSX (0.43x), BIIB (0.34x), BIO (0.18x), NTRA (0.14x), NTLA (0.13x).
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master RXRX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RXRX research report →RXRX
0.02x
Sector Median
0.43x
Sector Avg
0.81x
How RXRX's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.